Global assessments at six and 24 hours better with NSAID use, and fewer adverse effects, including bleeding events, reported
MONDAY, June 14, 2021 (HealthDay News) — For adult outpatients, use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with better pain scores and better global assessments, according to a review published online June 14 in CMAJ, the journal of the Canadian Medical Association.
Matthew Choi, M.D., M.P.H., from McMaster University in Hamilton, Ontario, Canada, and colleagues compared codeine and NSAIDs for postoperative pain in outpatient surgery in a systematic review and meta-analysis of randomized controlled trials. The patient pain score, converted to a standard 10-point intensity scale, was the primary outcome. Data were included for 40 studies, with 102 trial arms and 5,116 patients.
The researchers found that NSAIDs were associated with better pain scores at six and 12 hours (weighted mean differences, 0.93 and 0.79 points, respectively) compared with codeine. At six hours, stronger NSAID superiority was seen in trials where acetaminophen was coadministered at equivalent doses between the groups (weighted mean difference, 1.18). Better global assessments were seen at six hours and at 24 hours in association with NSAIDs (weighted mean differences, −0.88 and −0.67, respectively). In addition, NSAIDs were associated with fewer adverse effects, including bleeding events.
“These findings strengthen existing evidence and are broadly generalizable to patients across surgical disciplines,” the authors write. “Further studies should assess the comparative effectiveness of other nonopioid analgesics, and test these findings in other populations and settings.”
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions